- May 01, 2011
AMSTERDAM, NETe ERLANDS | Clondalkin intends to rebrand all of its North American and European pharmaceutical and healthcare companies as Clondalkin Pharma & Healthcare effective June 13. The company operates 18 pharmaceutical and healthcare-accredited production facilities in North America and Europe with annual sales of approximately $350 million.
The renamed North American operations include Keller Crescent and Catalent Printed Components. European operations include Pharmagraphics Guy, Kenilworth Products, Catalent, and Cahill Printers in Ireland; Boxes Prestige, Ditone, and Harlands in the UK; Cartonplex in Spain; and Boxes and Harlands in Poland.
What's happening at your company? Send your news to firstname.lastname@example.org.